Oncotarget is a renowned, open access journal that focuses primarily on oncology and cancer research. As a peer-reviewed publication, it ensures the highest standards of scientific integrity and editorial policies. The journal aims to maximize the impact of research by fostering insightful peer-review, bridging different fields of oncology and biomedical sciences, and promoting the application of both basic and clinical science.

The unique scope of Oncotarget encompasses all aspects related to cancer, including molecules, pathways, cellular functions, cell types, and even tissues that can be considered relevant targets in cancer treatment and other diseases. The journal follows a continuous publishing model, where papers are released within yearly volumes in their final and complete form, ensuring timely dissemination of valuable research findings. With its commitment to excellence, Oncotarget plays a vital role in advancing the field of oncology.

It is indexed and archived on prestigious platforms like MEDLINE, PMC, and PubMed, and has received high impact factor recognition. Researchers and professionals in the field trust Oncotarget as a valuable resource for cutting-edge discoveries and insights that drive progress in cancer research